ARCUTIS BIOTHERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.42 USD | +15.87% |
|
+18.87% | +194.04% |
| 06:04pm | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
| 03:20pm | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Bio Therapeutic Drugs | +16.48% | +18.87% | +194.04% | -7.79% | - | 939M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ARQT Stock
- Charts Arcutis Biotherapeutics, Inc.
- Comparison Chart